JPRN-UMIN000025927已完成未知
Patient's acceptance of non-stick method for anesthesia of trannasal endoscopy - Patient's acceptance of non-stick method for anesthesia of trannasal endoscopy
Medical corporation Yamashita Hospital0 个研究点目标入组 800 人开始时间: 2017年1月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases with severe complications are excluded
研究者
相似试验
尚未招募
Unknown
Practice of informed consent in patients undergoing abdominal operations electivelyCTRI/2024/06/068569Kasturba Medical College
尚未招募
不适用
Patient-centred implementation of elective single embryo transfer (eSET) in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI).Subfertiliteit, Paren die IVF/ICSI behandeling zullen ondergaanEvaluation of assisted reproductionSubfertility treatmentNL-OMON30404Academisch Medisch Centrum210
已完成
不适用
Patient controlled analgesia in emergency departmentsACTRN12617001559303atasya Raja (PhD Candidate)13
已完成
4 期
A study on the procedure for treatment switch to epoetin beta pegol in the treatment of renal anemia in maintenance hemodialysis patientsRenal Anemia Patients on HemodialysisJPRN-UMIN000008090Faculty of medicine, University of Miyazaki30
进行中（未招募）
1 期
The aim of the study is to provide patients with certain kinds of cancer continued access to the same drug they have received in a previous study, if they have benefited from the use of the drug.The patient population will consist of patients who have previously received and tolerated ixazomib in a Millennium-sponsored clinical study, and in the investigator’s opinion and confirmed by the Millennium medical monitor, may benefit from continued ixazomib therapy. In Belgium the indication of the parent study is relapsed and/or refractory Follicular LymphomaMedDRA version: 20.0Level: LLTClassification code 10029478Term: Nodular lymphomaSystem Organ Class: 100000004864EUCTR2016-001681-28-BEMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited250